Bronchial Thermoplasty Catheter Market

The Bronchial Thermoplasty Catheter Market size was valued at USD 3.95 Bn in 2025 and the total Bronchial Thermoplasty Catheter revenue is expected to grow at a CAGR of 5.1 % from 2026 to 2032, reaching nearly USD 5.59 Bn

Asthma is a chronic aliment wherein the airways become narrowl and produce excess mucus. This results in difficulty in breathing triggering cough while breathing out & shortness of breath. The severity of the disorders varies from patient to patient. Lot of patients are suffering from severe asthma. The current treatment available for the disorders creating significant unmet demand for improving treatment for patients with severe asthma.

Bronchial thermoplasty (BT), is a long-lasting solution for such patients. BT(Bronchial thermoplasty) is a non-drug treatment procedure for severe asthma in adults. The procedure is minimally invasive solution which is expected to complement conventional asthma drugs, improving symptoms and the patient life.

The high prevalence of asthma worldwide along with increasing demand for minimally invasive procedures is the key factor driving the demand for bronchial thermoplasty catheter market.The growing expenditure by the governments across the globe to develop healthcare infrastructure is also expected to be a important growth influencing factor for the bronchial thermoplasty market.

To know about the Research Methodology :- Request Free Sample Report

Bronchial Thermoplasty Catheter Market Dynamics:

The increasing prevalence of Asthma to drive market growth

The susceptibility to dust allergies, genetics & smoking are the leading causes of asthma among the population. The increasing amount of air pollution is also contributing to the growing prevalence of asthma. The high prevalence is creating huge demand for asthma treatment which is still unmet with limited options available in the market. The bronchial thermoplasty is the latest solution in the market and thus have a huge unmet market demand due to the high asthma prevalence & limited options for treatment.

Increasing Demand for Minimally Invasive Procedures to Drive the Bronchial Thermoplasty Catheter Market

The preference for minimally invasive treatment options is growing among patients. Shorter hospitals stays, high quality treatment & easier recovery are increasing the preference for minimally invasive treatment. The better outcomes & minimal damage from the treatment are resulting increased adoption of such solutions by the physicians.

The advancement in the technology is further driving the demand for minimally invasive procedures. In the U.S., the adoption of latest technology & better healthcare infrastructure has resulted in high scope for minimally invasive solutions in the region. The growing geriatric population globally is further increasing the preference for minimally invasive techniques as the elder people can’t withstand higher damage & long recovery time. The high disease prevalence in children is also driving the need for minimally invasive procedure to make their recovery comfortable. The high demand & scope of minimally invasive procedures is expected to increase the demand for bronchial thermoplasty, driving the bronchial thermoplasty catheter market growth.

Bronchial Thermoplasty Catheter Market Segment Analysis:

Based on End User

The global Bronchial Thermoplasty Catheter market is segmented into hospitals & ambulatory surgery centres. The ambulatory surgery centres accounted for the highest market share in 2025. Ambulatory surgery centre are specialised surgical facilities, wherein the patient does not require hospitalization. The comfortable environment & dedicated excellent care the facilities are responsible for the patient preferring an ambulatory surgery centre over hospitals. The lower cost of treatment compared to hospitals drives the preference for the ambulatory surgery centres.

The hospitals segment is expected to have the fastest growth during the forecast period. Availability of skilled healthcare professionals, better infrastructure, and the increasing prevalence of asthma in the geriatric population are key factors driving the segment. The hospitals are investing in updating their technologies to facilitate minimally invasive procedures for the patient, driving the market growth.

Bronchial Thermoplasty Catheter Market Regional Insights:

North America dominated the Bronchial Thermoplasty Catheter Market in 2025. The region has advanced healthcare infrastructure, high adoption of minimally invasive pulmonary procedures, and strong awareness regarding severe asthma management. The region benefited from early regulatory approvals and the commercial availability of the Alair Bronchial Thermoplasty System developed by Boston Scientific Corporation, which remains a leading technology in this space. The United States accounted for the largest share due to favorable reimbursement coverage, increasing prevalence of severe asthma, and the presence of well-established interventional pulmonology centers. Canada also contributed steadily with expanding access to specialized respiratory care services. Additionally, strong clinical research activities, growing physician training programs, and higher healthcare spending per capita supported procedural volumes across hospitals and ambulatory surgical centers.

Recent Developments 

February 2024: Boston Scientific strengthened its respiratory intervention portfolio, continuing commercial expansion of bronchial thermoplasty solutions for severe asthma management while investing in physician training programs globally. October 2025: The company streamlined selected cardiovascular segments to focus on high-growth interventional platforms, indirectly supporting pulmonary device innovation. January 2026: It reported strong procedural growth across interventional specialties, including pulmonary care, reinforcing its commitment to minimally invasive respiratory technologies.

March 2024: Medtronic expanded its minimally invasive therapies segment, emphasizing respiratory and airway management technologies integrated with advanced energy systems. September 2025: The company continued portfolio optimization efforts, reallocating capital toward high-margin interventional platforms and next-generation catheter-based technologies. February 2026: Medtronic highlighted sustained growth in advanced ablation and catheter solutions, strengthening its broader pulmonary and airway intervention ecosystem through innovation and global commercialization initiatives.

Bronchial Thermoplasty Catheter Market Scope: Inquire before buying

Bronchial Thermoplasty Catheter Market, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Key players/Competitors profiles covered in the Bronchial Thermoplasty Catheter Market report from a strategic perspective

1. Boston Scientific Corporation
2. Medtronic plc
3. Olympus Corporation
4. Johnson & Johnson (Ethicon)
5. Abbott Laboratories
6. Teleflex Incorporated
7. Cook Medical LLC
8. Merit Medical Systems, Inc.
9. AngioDynamics, Inc.
10. R. Bard, Inc.
11. Stryker Corporation
12. Terumo Corporation
13. CONMED Corporation
14. Ambu A/S
15. Fujifilm Holdings Corporation
16. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
17. Broncus Medical, Inc.
18. Veran Medical Technologies, Inc.
19. EMcision Ltd.
20. AtriCure, Inc.
21. Penumbra, Inc.
22. Smith & Nephew plc
23. Novate Medical Ltd.
24. BTG International Ltd.
25. Seawon Meditech Co., Ltd.
26. Sungwon Medical Co., Ltd.
27. Genoss Co., Ltd.
28. Transcath Medical
29. Olympic Medical Corp.
30. Endocare, Inc.